LONSURF
*Company:
Servier Laboratories Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 23 August 2023
File name
Lonsurf PIL.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 27 July 2023
File name
Lonsurf SmPC.pdf
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to restricted prescription (C)
Updated on 27 July 2023
File name
Lonsurf PIL.pdf
Reasons for updating
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 23 January 2023
File name
Lonsurf SmPC.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to restricted prescription (C)
Updated on 28 February 2022
File name
Lonsurf PIL.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 05 October 2021
File name
Lonsurf SmPC.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to restricted prescription (C)
Updated on 16 September 2021
File name
Lonsurf SmPC.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Product subject to restricted prescription (C)
Updated on 16 September 2021
File name
Lonsurf PIL.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - what the product looks like and pack contents
- Change to date of revision
Updated on 16 December 2020
File name
Lonsurf SmPC.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
- Removal of Black Inverted Triangle
Legal category:Product subject to restricted prescription (C)
Updated on 16 December 2020
File name
Lonsurf PIL.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Removal of Black Inverted Triangle
- Change to date of revision
Updated on 24 July 2020
File name
Lonsurf Common PIL.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 06 May 2020
File name
Lonsurf PIL.pdf
Reasons for updating
- Change to date of revision
Updated on 20 April 2020
File name
Lonsurf PIL.pdf
Reasons for updating
- Change to section 3 - how to take/use
- Change to section 4 - how to report a side effect
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 07 April 2020
File name
Lonsurf SmPC.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to restricted prescription (C)
Updated on 11 September 2019
File name
Lonsurf SmPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 11 September 2019
File name
Lonsurf PIL.pdf
Reasons for updating
- Change to section 1 - what the product is used for
- Change to section 4 - possible side effects
Updated on 25 April 2017
File name
PIL_16990_143.pdf
Reasons for updating
- New PIL for new product
Updated on 25 April 2017
Reasons for updating
- Change to section 4 - possible side effects
Updated on 10 November 2016
Reasons for updating
- New PIL for new product
- New PIL for medicines.ie